Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Masimo Corp MASI

Healthcare Medical Devices
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital... see more

Recent & Breaking News (NDAQ:MASI)

Masimo and MS Westfalia GmbH (MSW) Expand Partnership to Add Masimo SedLine® Brain Function Monitoring, O3® Regional Oximetry, and Oxygen Reserve Index (ORi(TM)) to the MSW Modular Point-of-Care Hybrid Jenny

Business Wire February 25, 2020

Masimo to Present at Raymond James 41st Annual Institutional Investors Conference

Business Wire February 24, 2020

Masimo Reports Fourth Quarter and Full-Year 2019 Financial Results

Business Wire February 19, 2020

Masimo to Report Fourth Quarter and Full Year 2019 Financial Results after Market Close on Wednesday, February 19

Business Wire February 12, 2020

Masimo Announces Select Preliminary Full-Year 2019 Financial Results and 2020 Guidance

Business Wire January 14, 2020

Masimo to Acquire Connected Care Business from NantHealth

Business Wire January 14, 2020

Masimo Announces FDA Clearance for Neonatal RD SET® Pulse Oximetry Sensors with Improved Accuracy Specifications

Business Wire December 30, 2019

Masimo and Dräger Expand Licensing Agreement to Add Masimo Brain Monitoring and Capnography Technologies

Business Wire December 19, 2019

Masimo to Present at Evercore ISI 2nd Annual HealthCONx Conference

Business Wire December 2, 2019

Masimo to Present at Piper Jaffray 31st Annual Healthcare Conference

Business Wire November 27, 2019

Study Uses Masimo Patient SafetyNet(TM) and rainbow Acoustic Monitoring® to Investigate the Incidence of Desaturation and Bradypnea in Postoperative Patients

Business Wire November 21, 2019

Masimo to Present at Stifel 2019 Healthcare Conference

Business Wire November 13, 2019

Masimo Announces CE Marking of Radius Capnography(TM) for the Root® Patient Monitoring and Connectivity Platform

Business Wire October 31, 2019

Masimo Reports Third Quarter 2019 Financial Results

Business Wire October 30, 2019

Study Investigates Effects of Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, on Postoperative Anemia and Inappropriate Blood Transfusion in Patients Undergoing Hip and Knee Surgery

Business Wire October 23, 2019

Masimo to Report Third Quarter 2019 Financial Results after Market Close on Wednesday, October 30

Business Wire October 16, 2019

Study Investigates the Ability of Masimo Noninvasive, Continuous Hemoglobin (SpHb®) to Provide Earlier Indication of Anemia and the Impact of Anemia on Patient Outcomes

Business Wire September 23, 2019

Masimo Announces Development of Delta cHb, HHb, and O2Hb Indices for O3®

Business Wire September 9, 2019

Masimo to Present at Morgan Stanley 17th Annual Global Healthcare Conference

Business Wire September 4, 2019

Masimo Announces Pathway(TM), a Newborn Oxygenation Visualization Mode for the Root® Patient Monitoring and Connectivity Platform

Business Wire September 4, 2019